Effects of oligomeric grape seed proanthocyanidins on heart, aorta, kidney in DOCA-salt mice: Role of oxidative stress

Phytotherapy Research

Volumn 27, Issue 6, 2013, Pages 869-876

  Wang, Xing Hui ^a   Huang, Ling Ling ^a   Yu, Ting Ting ^a   Zhu, Jin Hang ^a   Shen, Bing ^a   Zhang, Ye ^a   Wang, Hong Zhi ^b   Gao, Shan ^a  

^a ANHUI MEDICAL UNIVERSITY   (China)

^b HEFEI INSTITUTES OF PHYSICAL SCIENCE   (China)

Author keywords

cardiovascular remodeling; endothelial dysfunction; grape seed proanthocyanidins; kidney hypertrophy; malondialdehyde; nitric oxide

Indexed keywords

AMLODIPINE; COLLAGEN; DEOXYCORTICOSTERONE ACETATE; GRAPE SEED EXTRACT; HYDROXYPROLINE; MALONALDEHYDE; NITRIC OXIDE; OLIGOMER; PROANTHOCYANIDIN DERIVATIVE; SODIUM CHLORIDE; SUPEROXIDE DISMUTASE; TEMPOL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA DISEASE; ARTICLE; BLOOD LEVEL; BODY WEIGHT; CARDIOVASCULAR DISEASE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; HEART MUSCLE CELL; HEART WEIGHT; HEART WEIGHT INDEX; HISTOPATHOLOGY; IN VITRO STUDY; KIDNEY HYPERTROPHY; KIDNEY MASS; KIDNEY WEIGHT INDEX; MALE; MALONDIALDEHYDE BLOOD LEVEL; MOUSE; NITRIC OXIDE BLOOD LEVEL; NONHUMAN; OXIDATIVE STRESS; PROTEIN LOCALIZATION; THORACIC AORTA; TREATMENT DURATION; VASCULAR ENDOTHELIUM; VASODILATATION;

ANIMALS; AORTA; BODY WEIGHT; DESOXYCORTICOSTERONE; GRAPE SEED EXTRACT; HEART; KIDNEY; MALE; MALONDIALDEHYDE; MICE; MYOCARDIUM; NITRIC OXIDE; ORGAN SIZE; OXIDATIVE STRESS; PROANTHOCYANIDINS; SUPEROXIDE DISMUTASE; VENTRICULAR REMODELING; VITIS;

MUS; VITACEAE;

EID: 84878834534     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4793     Document Type: Article

References (26)

1. Beswick RA, Dorrance AM, Leite R, Webb RC,. 2001. NADH/NADPH oxidase and enhanced superoxide production in the mineralocorticoid hypertensive rat. Hypertension 38: 1107-1111.
2. Bolterman RJ, Manriquez MC, Ortiz Ruiz MC, Juncos LA, Romero JC,. 2005. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats. Hypertension 46: 943-947.
3. Chan V, Hoey A, Brown L,. 2006. Improved cardiovascular function with aminoguanidine in DOCA-salt hypertensive rats. Br J Pharmacol 148: 902-908.
4. Edirisinghe I, Burton-Freeman B, Tissa Kappagoda C,. 2008. Mechanism of the endothelium-dependent relaxation evoked by a grape seed extract. Clin Sci (Lond) 114: 331-337.
5. Galisteo M, Garcia-Saura MF, Jimenez R, et al,. 2004. Effects of quercetin treatment on vascular function in deoxycorticosterone acetate-salt hypertensive rats: comparative study with verapamil. Planta Med 70: 334-341.
6. ATP activation prevents progression of cardiac hypertrophy to failure induced by pressure overload via protecting endothelial function. Cardiovasc Res 83: 444-456.
7. Guo DF, Chenier I, Lavoie JL, et al,. 2006. Development of hypertension and kidney hypertrophy in transgenic mice overexpressing ARAP1 gene in the kidney. Hypertension 48: 453-459.
8. Jadhav A, Torlakovic E, Ndisang JF,. 2009. Hemin therapy attenuates kidney injury in deoxycorticosterone acetate-salt hypertensive rats. Am J Physiol Renal Physiol 296: F521-F534.
9. Majid DSA, Kopkan L,. 2007. Nitric oxide and superoxide interactions in the kidney and their implication in the development of salt-sensitive hypertension. Clin Exp Pharmacol Physiol 34: 946-952.
10. Nakanishi K, Hara N, Nagai Y,. 2002. Salt-sensitive hypertension in conscious rats induced by chronic nitric oxide blockade. Am J Hypertens 15: 150-156.
11. Nandakumar V, Singh T, Katiyar SK,. 2008. Multi-targeted prevention and therapy of cancer by proanthocyanidins. Cancer Lett 269: 378-387.
12. Ndisang JF, Jadhav A,. 2010. Heme arginate therapy enhanced adiponectin and atrial natriuretic peptide, but abated endothelin-1 with attenuation of kidney histopathological lesions in mineralocorticoid-induced hypertension. JPET 334: 87-98.
13. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE,. 1990. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323: 22-27.
14. 2 receptors play a role? Hypertension 33: 329-334.
15. Richard MJ, Portal B, Meo J, Coudray C, Hadjian A, Favier A,. 1992. Malondialdehyde kit evaluated for determining plasma and lipoprotein fractions that react with thiobarbituric acid. Clin Chem 38: 704-709.
16. Richey PA, Brown SP,. 1998. Pathological versus physiological left ventricular hypertrophy: a review. J Sports Sci 16: 129-141.
17. Sakurai T, Kitadate K, Nishioka H, et al,. 2010. Oligomerized grape seed polyphenols attenuate inflammatory changes due to antioxidative properties in coculture of adipocytes and macrophages. J Nutr Biochem 21: 47-54.
18. Seifi B, Kadkhodaee M, Karimian SM, Zahmatkesh M, Xu J, Soleimani M,. 2010. Evaluation of renal oxidative stress in the development of DOCA-salt induced hypertension and its renal damage. Clin Exp Hypertens 32: 90-97.
19. Shao ZH, Wojcik KR, Dossumbekova A, et al,. 2009. Grape seed proanthocyanidins protect cardiomyocytes from ischemia and reperfusion injury via Akt-NOS signaling. J Cell Biochem 107: 697-705.
20. Takimoto E, Kass DA,. 2007. Role of oxidative stress in cardiac hypertrophy and remodeling. Hypertension 49: 241-248.
21. Tolins JP, Shultz PJ,. 1994. Endogenous nitric oxide synthesis determines sensitivity to the pressor effect of salt. Kidney Int 46: 230-236.
22. Veltkamp R, Rajapakse N, Robins G, Puskar M, Shimizu K, Busija D,. 2002. Transient focal ischemia increases endothelial nitric oxide synthase in cerebral blood vessels. Stroke 33: 2704-2710.
23. Watts SW, Rondelli C, Thakali K, et al,. 2007. Morphological and biochemical characterization of remodeling in aorta and vena cava of DOCA-salt hypertensive rats. Am J Physiol Heart Circ Physiol 292: H2438-2448.
24. Yousef MI, Saad AA, El-Shennawy LK,. 2009. Protective effect of grape seed proanthocyanidin extract against oxidative stress induced by cisplatin in rats. Food Chem Toxicol 47: 1176-1183.
25. Zhang Y, Chan MM, Andrews MC, et al,. 2005. Apocynin but not allopurinol prevents and reverses adrenocorticotropic hormone-induced hypertension in the rat. Am J Hypertens 18: 910-916.
26. Zhang Y, Jang R, Mori TA, et al,. 2003. The anti- oxidant tempol reverses and partially prevents adrenocorticotrophic hormone-induced hypertension in the rat. J Hypertension 21: 1513-1518.